The authors reported a cross-sectional cohort of 266 university employees from a public university in Maharashtra, India who completed a comprehensive health assessment programme. Investigators used predefined disease lists to classify multimorbidity: the study defined multimorbidity as two or more of nine chronic conditions and defined cardiometabolic multimorbidity as two or more of five cardiovascular and metabolic conditions. Ethics approval was recorded from the Institutional Ethics Committee of Savitribai Phule Pune University (Approval No. SPPU/IEC/2019/07).
Screening uncovered substantial undiagnosed disease. Hypertension was present in 119 participants (44.7%); of these, 50 had a prior diagnosis and 69 were newly identified during the assessment. Dyslipidaemia was the most common finding, recorded in 189 participants (71.1%), and diabetes mellitus was present in 45 participants (16.9%). Overall, 173 participants (65.0%) had at least one newly identified diagnosis among hypertension, diabetes mellitus or dyslipidaemia discovered through the programme.
Data indicated that 108 participants (40.6%) met the study threshold for multimorbidity. Nearly the same proportion—103 participants (38.7%)—met the narrower definition of cardiometabolic multimorbidity. Disease clustering leaned heavily toward vascular and metabolic conditions rather than non-cardiometabolic diagnoses in this cohort.
The most frequent exact patterns were simple and recognizable: hypertension plus dyslipidaemia alone occurred in 49 participants. A three-condition cluster—hypertension, diabetes mellitus and dyslipidaemia—was recorded in 27 participants. Age-stratified prevalence rose steeply; the investigators reported a jump from 17.5% multimorbidity prevalence among participants aged under 30 years to 83.3% among those aged 60 years or older. The report did not provide additional breakdowns by occupational role or worksite exposure beyond the university employee population.
Investigators applied multivariable logistic regression to evaluate correlates of multimorbidity. The model identified three independent predictors: older age (adjusted OR 1.058 per year), higher body mass index (adjusted OR 1.163 per kg/m2) and tobacco use (adjusted OR 3.296). The authors reported the model discrimination as moderate, with an area under the receiver operating characteristic curve of 0.731.
The study flagged BMI and tobacco use as modifiable risk factors associated with clustering of chronic conditions in this working-age population. The authors did not report additional behavioural or socioeconomic variables in the abstract; details beyond the variables noted here were not provided in the accessible summary.
The screening programme identified a high prevalence of both known and previously unrecognised chronic disease among university employees, with cardiometabolic conditions accounting for most of the observed clustering. Investigators suggested that integrating institutional or occupational health assessments with longitudinal primary care follow-up could create opportunities for earlier detection, targeted risk-factor modification and coordinated management of multimorbidity.
The authors declared no competing interests and confirmed adherence to ethical guidelines; the Institutional Ethics Committee of Savitribai Phule Pune University approved the study. The preprint notes that all data produced are available upon reasonable request to the authors.
Limitations reported in the preprint include those inherent to its cross-sectional design: temporal relationships and causal inference cannot be established from these data. The abstract did not provide details on sampling strategy, response rate, or the specific screening methods and diagnostic cutoffs used for each condition; those methodological elements were not reported in the abstract and therefore are not recounted here. The preprint status indicates the findings have not undergone peer review; investigators and readers should treat the results as preliminary and await peer-reviewed confirmation or additional analyses.
Unanswered clinical questions that remain in the report include the longitudinal outcomes of those newly diagnosed through screening, the effectiveness of linking institutional screening to primary care in this setting, and whether targeted interventions would alter the observed age and BMI gradients in multimorbidity. The authors proposed integrating these assessments with follow-up care but did not provide tested implementation details in the preprint.